WILMINGTON, Del., May 10, 2010 (BUSINESS WIRE) -- Synchrogenix Information Strategies Inc. is expanding its strategic regulatory writing workforce for the third time in 2 years, creating 40 new jobs around the world, despite the flailing economy.
"More and more pharmaceutical and biotech companies are relying on us as a strategic sourcing partner, because our regulatory writers and subject matter experts fit seamlessly and naturally into client teams," CEO Ellen Barrosse said. "Our team members come from various roles in the pharmaceutical industry, which enables us to provide our clients with the holistic expertise necessary to create relevant submission-ready documents." In the past three months, Synchrogenix has hired 19 new employees, including 16 experienced regulatory writers and three support staff. Synchrogenix also is moving its offices in High Wycombe, U.K., and Malvern, Pa., to larger spaces, and signed a lease last week for its new office in Cambridge, Mass.
"Experienced writers are attracted to Synchrogenix because we foster employee development and work-life balance," Barrosse said. "This helps our writers avoid burnout and reduces turnover, so our clients benefit from consistent teams of writers who get to know their products, processes, and expectations, building efficiencies as the partnership progresses." Synchrogenix will hire 21 additional writers by the end of the second quarter.
Synchrogenix also plans to add a senior project manager for regulatory documents and additional support staff.
This marks Synchrogenix's third major expansion in less than two years.
Synchrogenix opened its Malvern site in July 2008, its Asian subsidiary in September 2008, and its European subsidiary in April 2009. Synchrogenix will expand operations to Paris this summer and open at least one additional U.S.
office by the end of 2010, although the location has not yet been finalized.
Synchrogenix (www.synchrogenix.com) is a Delaware-based, woman-owned, medical/regulatory communications company. Established in 1986, Synchrogenix develops and writes strategic documents for the pharmaceutical and biotech industries. Synchrogenix Philippines, Inc. and Synchrogenix Europe Ltd are wholly owned subsidiaries of Synchrogenix Information Strategies Inc.
SOURCE: Synchrogenix Information Strategies Inc.
CONTACT: Synchrogenix Allison Taylor Levine, APR 302-345-0589 Allison.Levine@synchrogenix.com Copyright Business Wire 2010 -0- KEYWORD: United States
Delaware INDUSTRY KEYWORD: Health
Other Professional Services
Science SUBJECT CODE: Personnel